Literature DB >> 21854219

Kinetics of c-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life times.

Saori Takata1, Hiroo Wada, Masaki Tamura, Takashi Koide, Manabu Higaki, Shin-Ichiro Mikura, Tetsuo Yasutake, Susumu Hirao, Masuo Nakamura, Koujiro Honda, Tomoko Nagatomo, Yasutaka Tanaka, Erei Sohara, Masato Watanabe, Takuma Yokoyama, Takeshi Saraya, Daisuke Kurai, Haruyuki Ishii, Hajime Goto.   

Abstract

Context: In management of community-acquired pneumonia (CAP), excellent biomarkers for inflammation would be helpful in our practice.
Objectives: Kinetics of c-reactive protein (CRP) and serum amyloid A (SAA) was characterized, using their biologic half-life times. Materials and methods: Time course of CRP and SAA levels in the successfully treated 36 CAP patients were investigated and their half-life times were determined and compared. Results & Discussions: SAA and CRP declined in an exponential mean and the biologic half-life times of SAA levels was 34.9 ± 28.7 h, significantly shorter than that of CRP, 46.4 ± 21.7 h (p = 0.0014).
Conclusion: The kinetic evidence, presented as biologic half-life times of CRP and SAA, helps us make a clinical assessment of CAP patients.

Entities:  

Year:  2011        PMID: 21854219     DOI: 10.3109/1354750X.2011.607189

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  11 in total

1.  The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling.

Authors:  Ida Netterberg; Mats O Karlsson; Elisabet I Nielsen; Angelica L Quartino; Henrik Lindman; Lena E Friberg
Journal:  Br J Clin Pharmacol       Date:  2018-01-18       Impact factor: 4.335

2.  Serum Amyloid A as a Biomarker for Radiation Exposure.

Authors:  Mary Sproull; Tamalee Kramp; Anita Tandle; Uma Shankavaram; Kevin Camphausen
Journal:  Radiat Res       Date:  2015-06-26       Impact factor: 2.841

3.  Relationship between biomarkers and findings on low-dose computed tomography in hospitalised patients with acute exacerbation of COPD.

Authors:  Hendrik J Prins; Ruud Duijkers; Gerdien Kramer; Els Boerhout; Floris J Rietema; Pim A de Jong; Marianne I Schoorl; Tjip S van der Werf; Wim G Boersma
Journal:  ERJ Open Res       Date:  2022-06-20

4.  Elevated serum amyloid A is associated with venous thromboembolism.

Authors:  Hiroshi Deguchi; Darlene J Elias; Silvia Navarro; Francisco España; John H Griffin
Journal:  Thromb Haemost       Date:  2012-12-20       Impact factor: 5.249

5.  Mechanism-based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study).

Authors:  Shuji Ohta; Tomomi Tsuru; Kimio Terao; Seiji Mogi; Midori Suzaki; Eisuke Shono; Yoshimasa Ishida; Eriko Tarumi; Masato Imai
Journal:  J Clin Pharmacol       Date:  2013-10-12       Impact factor: 3.126

6.  Characterization of the contributions of Hp-MMP 9 to the serum acute phase protein response of lipopolysaccharide challenged calves.

Authors:  Charles A Hinds; Andrew J Niehaus; Christopher Premanandan; Paivi J Rajala-Schultz; Donald M Rings; Jeffrey Lakritz
Journal:  BMC Vet Res       Date:  2014-10-30       Impact factor: 2.741

7.  Usefulness of the heparin-binding protein level to diagnose sepsis and septic shock according to Sepsis-3 compared with procalcitonin and C reactive protein: a prospective cohort study in China.

Authors:  Yixuan Zhou; Zhen Liu; Jun Huang; Guiling Li; Fengying Li; Yulan Cheng; Xinyou Xie; Jun Zhang
Journal:  BMJ Open       Date:  2019-04-23       Impact factor: 2.692

8.  Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker.

Authors:  Yong Gil Hwang; Goundappa K Balasubramani; Ilinca D Metes; Marc C Levesque; S Louis Bridges; Larry W Moreland
Journal:  Arthritis Res Ther       Date:  2016-05-17       Impact factor: 5.156

9.  A Clinical Prediction Score Including Trial of Antibiotics and C-Reactive Protein to Improve the Diagnosis of Tuberculosis in Ambulatory People With HIV.

Authors:  Tom H Boyles; Matilda Nduna; Thalitha Pitsi; Lesley Scott; Matthew P Fox; Gary Maartens
Journal:  Open Forum Infect Dis       Date:  2020-01-06       Impact factor: 3.835

10.  Serum amyloid A levels in patients with liver diseases.

Authors:  Zi-Ying Yuan; Xing-Xin Zhang; Yu-Jing Wu; Zhi-Ping Zeng; Wei-Min She; Shi-Yao Chen; Yuan-Qing Zhang; Jin-Sheng Guo
Journal:  World J Gastroenterol       Date:  2019-11-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.